Lack of Processing of the Expressed ORF1 Gene Product of Hepatitis E Virus
© Suppiah et al; licensee BioMed Central Ltd. 2011
Received: 22 April 2011
Accepted: 20 May 2011
Published: 20 May 2011
Proteolytic processing is a common mechanism among plus strand RNA viruses and the replicases of all plus strand RNA viruses of animals thus far characterized undergo such processing. The replicase proteins of hepatitis E virus (HEV) are encoded by ORF1. A previous report published by our group  provided data that processing potentially occurred when ORF1 (Burma strain; genotype 1) was expressed using a vaccinia virus-based expression system.
To further test for processing and to rule out artifacts associated with the expression system, ORF1 was re-expressed using a plasmid-based expression vector with the result that the previous processing profile could not be confirmed. When ORF1 from an HEV infectious cDNA clone (US swine strain; genotype 3) was expressed using the plasmid-based system, the only species detected was the 185 kDa precursor of ORF1. A putative papain-like cysteine protease  had been predicted within ORF1 using the original HEV genomic sequence. However, analysis of subsequent ORF1 sequences from a large number of HEV isolates reveals that this protease motif is not conserved.
The expressed HEV ORF1 gene product does not undergo proteolytic processing, indicating that the replicase precursor of HEV is potentially unique in this regard.
Proteolytic processing of replicase polyprotein precursors into mature protein products is a common mechanism among plus-sense RNA viruses and has been demonstrated for all plus-sense RNA viruses of animals. HEV is most closely related to the two genera of the Togaviridae family, the alphavirus genus and the rubivirus genus. The replicase precursors of the viruses in these genera are processed into four and two mature proteins, respectively [8, 9]. For both of these genera, it has been shown that processing regulates the synthesis of plus- and minus-strand RNA synthesis [10, 11]. Because the enzyme responsible for proteolytic processing resides within the precursor, authentic processing occurs when the replicase precursor is expressed. Processing of the primary HEV ORF1 translation product, which has a putative MW of ~185 kDa, has not been resolved. No processing was detected when ORF1 was translated in vitro and the main product following expression of ORF1 in a number of mammalian cell lines was the ~185 kDa uncleaved species, however putative processing products were detected [1, 12]. Expression of ORF1 by baculovirus in insect cells yielded a putative total of eight cleavages .
With respect to our earlier study, vaccinia virus-based expression of ORF1 derived from the human Burma strain of HEV (genotype 1) revealed the presence of putative N- and C-terminal products of 78 kDa and 107 kDa as well as the 185 kDa uncleaved species . However, mutation of the putative catalytic cysteine (C483) of the predicted protease catalytic site within ORF1 did not eliminate these products and thus it could not be ruled out this processing might be due to the expression system employed. Therefore, to begin this follow up study, we tried expression of the Burma strain ORF1 using a protease-free vector, namely a plasmid vector, VR1012 (Vical, Inc., San Diego, CA), in which expression is driven by the human cytomegalovirus (CMV) immediate early promoter. In this construct, ORF1 was tagged at its N- and C-termini with FLAG and HA epitopes, respectively. This time, the 185 kDa uncleaved product was again the predominant species, however a putative N- terminal product with an apparent molecular weight of 115 kDa was detected with no corresponding putative C-terminal product (data not shown).
As a positive control to determine if processing of a virus nonstructural replicase protein precursor could be detected using this expression system, the rubella virus nonstructural protein ORF (which corresponds to ORF1 of HEV) from an infectious cDNA clone of rubella virus  was also provided with N-terminal FLAG and C-terminal HA tags and cloned into the VR1012 vector, yielding a construct termed pCMV-NS-ORF. As shown in Figure 2C and 2D, when this construct was expressed, the N-terminal P150 protein was detected with anti-FLAG antibody and the C-terminal P90 protein was detected with anti-HA antibody. No 240 kDa precursor product was detected with either antibody, indicating that processing was complete.
Taken together, there is no consistent evidence that the HEV ORF1 primary translation product undergoes proteolytic processing. Expressed ORF1 from an Indian strain of HEV (genotype 1) and US swine strain (genotype 3) exhibited no processing while potential processing products of the ORF1 of the human Burma strain (genotype 1) were not consistent between different expression systems and therefore are likely artifactual [1, 12]. ORF1 of the Indian strain underwent a complex processing scheme when in expressed by baculovirus in insect cells , but it must be considered that insects are not the natural hosts for HEV. HEV in vitro genomic and replicon (constructs in which the structural proteins are replaced with reporter genes) RNA transcripts that are infectious in both cell culture and animals have been available for several years [14, 16–20]. Despite the potential of these systems to resolve whether ORF1 processing occurs during replication, convincing evidence one way or the other has yet to be reported. Thus, HEV potentially is unique among plus-sense RNA viruses of animals in the feature of lacking proteolytic processing of its replicase precursor. In this regard, the catalytic residues of the putative PCP that was postulated to mediate processing of ORF1 were predicted on the basis of the original HEV sequence (genotype 1 Burma strain). Since that time, numerous additional sequences of HEV have been reported and four genotypes have been distinguished. A search of GenBank yielded 135 complete genomic sequences of HEV and alignment of ORF1 from these sequences revealed that while the putative catalytic cysteine residue (C483) of the predicted PCP is conserved across these sequences, the putative catalytic histidine residue is not (Figure 1). In fact the residue at position 590 of ORF1 is genotype specific: H in genotype 1, L in genotype 2, and predominantly Y in genotypes 3 and 4. Additionally, in the recently described avian HEV the region of ORF1 containing the predicted PCP is not present, consistent with lack of processing of ORF1 .
The research described in this report was conducted by SS as part of her PhD dissertation. SS is currently a Postdoctoral Fellow in the Department of Pathology, Emory University School of Medicine.
The research was supported by a grant from NIH (AI21389) to TKF. SS was a Fellow of the Molecular Basis of Disease Area of Focus, Georgia State University.
- Ropp SL, Tam AW, Beames B, Purdy M, Frey TK: Expression of the hepatitis E virus ORF1. Arch Virol 2000, 145: 1321-1337. 10.1007/s007050070093View ArticlePubMedGoogle Scholar
- Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW: Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci USA 1992, 89: 8259-8263. 10.1073/pnas.89.17.8259PubMed CentralView ArticlePubMedGoogle Scholar
- Meng XJ: Recent advances in Hepatitis E virus. J Viral Hepat 2010, 17: 153-161. 10.1111/j.1365-2893.2009.01257.xView ArticlePubMedGoogle Scholar
- Karpe YA, Lole KS: RNA 5'-triphosphatase activity of the hepatitis E virus helicase domain. J Virol 2010, 84: 9637-9641. 10.1128/JVI.00492-10PubMed CentralView ArticlePubMedGoogle Scholar
- Karpe YA, Lole KS: NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain. J Virol 2010, 84: 3595-3602. 10.1128/JVI.02130-09PubMed CentralView ArticlePubMedGoogle Scholar
- Magden J, Takeda N, Li T, Auvinen P, Ahola T, Miyamura T, Merits A, Kaariainen L: Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol 2001, 75: 6249-6255. 10.1128/JVI.75.14.6249-6255.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Rehman S, Kapur N, Durgapal H, Panda SK: Subcellular localization of hepatitis E virus (HEV) replicase. Virology 2008, 370: 77-92. 10.1016/j.virol.2007.07.036View ArticlePubMedGoogle Scholar
- Collins PL, Fuller FJ, Marcus PI, Hightower LE, Ball LA: Synthesis and processing of Sindbis virus nonstructural proteins in vitro. Virology 1982, 118: 363-379. 10.1016/0042-6822(82)90356-7View ArticlePubMedGoogle Scholar
- Marr LD, Wang CY, Frey TK: Expression of the rubella virus nonstructural protein ORF and demonstration of proteolytic processing. Virology 1994, 198: 586-592. 10.1006/viro.1994.1070View ArticlePubMedGoogle Scholar
- Liang Y, Gillam S: Mutational analysis of the rubella virus nonstructural polyprotein and its cleavage products in virus replication and RNA synthesis. J Virol 2000, 74: 5133-5141. 10.1128/JVI.74.11.5133-5141.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Shirako Y, Strauss JH: Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J Virol 1994, 68: 1874-1885.PubMed CentralPubMedGoogle Scholar
- Ansari IH, Nanda SK, Durgapal H, Agrawal S, Mohanty SK, Gupta D, Jameel S, Panda SK: Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol 2000, 60: 275-283. 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.0.CO;2-9View ArticlePubMedGoogle Scholar
- Sehgal D, Thomas S, Chakraborty M, Jameel S: Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol J 2006, 3: 38. 10.1186/1743-422X-3-38PubMed CentralView ArticlePubMedGoogle Scholar
- Huang YW, Haqshenas G, Kasorndorkbua C, Halbur PG, Emerson SU, Meng XJ: Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs. J Virol 2005, 79: 1552-1558. 10.1128/JVI.79.3.1552-1558.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Pugachev KV, Abernathy ES, Frey TK: Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins. J Virol 1997, 71: 562-568.PubMed CentralPubMedGoogle Scholar
- Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH: In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 2004, 78: 4838-4846. 10.1128/JVI.78.9.4838-4846.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Panda SK, Ansari IH, Durgapal H, Agrawal S, Jameel S: The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol 2000, 74: 2430-2437. 10.1128/JVI.74.5.2430-2437.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Huang FF, Pierson FW, Toth TE, Meng XJ: Construction and characterization of infectious cDNA clones of a chicken strain of hepatitis E virus (HEV), avian HEV. J Gen Virol 2005, 86: 2585-2593. 10.1099/vir.0.81070-0View ArticlePubMedGoogle Scholar
- Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Tanaka T, Okamoto H: Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells. J Gen Virol 2009, 90: 457-462. 10.1099/vir.0.007559-0View ArticlePubMedGoogle Scholar
- Thakral D, Nayak B, Rehman S, Durgapal H, Panda SK: Replication of a recombinant hepatitis E virus genome tagged with reporter genes and generation of a short-term cell line producing viral RNA and proteins. J Gen Virol 2005, 86: 1189-1200. 10.1099/vir.0.80705-0View ArticlePubMedGoogle Scholar
- Huang FF, Sun ZF, Emerson SU, Purcell RH, Shivaprasad HL, Pierson FW, Toth TE, Meng XJ: Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 2004, 85: 1609-1618. 10.1099/vir.0.79841-0View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.